Berapa harga Paion AG (PA8)

Harga Paion AG (PA8) adalah $0.42701586

Apa kapitalisasi pasar Paion AG (PA8)

Kapitalisasi pasar Paion AG (PA8) adalah $3.21M

Riwayat Harga Paion AG (PA8)

Paion AG is a specialized pharmaceutical firm engaged in the global development and commercialization of medicines for hospital settings, specifically addressing needs in sedation, anesthesia, and critical care. Its primary compound, Remimazolam, is an ultra-short-acting intravenous benzodiazepine designed as a sedative/anesthetic, currently progressing through clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline also includes Angiotensin II, a vasoconstrictor for treating severe low blood pressure in adults experiencing septic or other forms of distributive shock, and Eravacycline, a new fluorocycline antibiotic targeting complex intra-abdominal infections in adults. Paion AG collaborates with various partners through licensing and strategic agreements, including Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Established in 2000, Paion AG operates from Aachen, Germany.

Tahun	Performa
2023	-93.62%
2022	0.00%

Tahun

Performa

2023

-93.62%

2022

0.00%

Perusahaan	Harga saham	Perubahan 1th%	Negara
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$161.67	23.26%	DE
Takeda Pharmaceutical Company Limited 4502.T	$36.61	22.16%	JP
Galderma Group AG GALD.SW	$225.00	37.51%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$21.30	13.79%	IN

Perusahaan

Harga saham

Perubahan 1th%

Negara